Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK-580299) in Healthy Female Control Subjects From the Primary NCT00294047 Study

NCT01190189 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01190189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01190189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of GSK Biologicals' Human Papillomavirus Vaccine (GSK-580299) in Healthy Female Control Subjects From the Primary NCT00294047 Study
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
April 1, 2011
Completion date
November 23, 2017
Enrollment
137 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus